Press and Media

Thank you for your coverage of the AANEM Annual Meeting. Please join us at the 2025 AANEM Annual Meeting, being held Oct.29-Nov. 1 in San Francisco, California. Journalists covering the annual meeting and posting stories on social media channels are encouraged to use the official meeting hashtag #AANEMinSanFran.
Please review the Abstract Embargo Policy. For questions regarding AANEM Annual Meeting policies, please email communications@aanem.org.

View the latest AANEM Achievement Award winners, the American Neuromuscular Foundation (ANF) Abstract Award winners, and the latest AANEM news articles on News Express.

Questions? Check out the frequently asked questions below or contact communications@aanem.org

Frequently Asked Questions

Q: When will be content of abstracts be viewable, as opposed to just the titles?
A: The abstract content will be available at the annual meeting during the Poster Hall hours. We do not provide abstract presenter information or slides ahead of time. All available information can be found in the AANEM Abstract Guide online when it becomes available.

Q: How do I reach out to abstract or session presenters for an interview?
A:
 We do not offer member contact information. To connect with abstract or session presenters, review the AANEM Annual Meeting Program when available. Find the topics of interest and connect with the presenter after their lecture or during their abstract poster session time. Currently there is no interview option for virtual attendees.

Q: When can I share information?
A: The embargo on the abstracts themselves is lifted when they have been published in Muscle & Nerve and online in the AANEM Abstract Guide. However, the additional information beyond what is in the abstract itself is still embargoed. 

AANEM requires information that goes beyond that which is contained within the abstract, e.g., the release of data not included in the abstract, discussion of the abstract done as part of a scientific presentation, etc. to be embargoed until the start of the annual meeting. Please see the Abstract Embargo Policy.

Q: Will the Abstract Award Reception feature the best posters? 
A: The Abstract Award Reception is a social hour in honor of the abstract award winners where all authors, including award winners, will be available to discuss research. 

Q: Original research is ONLY presented as posters, correct?
A: Yes - the research is presented in the Poster Hall via abstract posters.

Science News: The Resisted Levator Scapulae Test: A Clinical Test for C4 Radiculopathy

Jun 15, 2026, 10:25 by DeeDee Stiepan
The findings from this study highlight the clinical application of the RLS test as a new bedside diagnostic tool for patients with C4 radiculopathy.

Submitted by: Elena Shanina, MD
Edited by: Rebecca O'Bryan, MD

Citation: Peters WR, Smith JTE, Zotti MG. The resisted levator scapulae test: a clinical test for C4 radiculopathy. Eur Spine J. 2025;34(8):3205-3213. doi:10.1007/s00586-025-08903-z

Summary: 
This study examined a novel clinical examination maneuver, the resisted levator scapular (RLS) test, as a potentially useful bedside tool for identifying isolated C4 radiculopathy. Because C4 radiculopathy lacks well-established physical examination findings, diagnosis can be challenging. Patients with clinical suspicion for C4 radiculopathy were enrolled in this study and were categorized either as a test group, who received CT-guided C4 nerve root injection as a diagnostic gold standard, or as a pragmatic control group based on imaging evidence of C3-4 foraminal stenosis. The performance of the RLS test was evaluated by comparing bedside clinical findings with diagnostic nerve block outcomes.

Twenty-five participants (12 male, 13 female) with a median age of 69 completed the study in the test group and 298 participants (192 male, 106 female) completed the study in the pragmatic control group. Among the patients in the test group, nine had isolated C4 radiculopathy confirmed by nerve block and 15 had multilevel involvement including C4. Primary analysis showed that the RLS test had a high sensitivity (90%) but low specificity (20%), suggesting it is good at detecting possible cases, but not strong at ruling out  mimics. Expanded analysis, which included the larger control group, considerably improved specificity (93%) and negative predictive value (99.6%).

The RLS test utilizes shoulder elevation and lateral flexion of the cervical spine, isolating the distal attachment of the levator scapulae at the medial border of the scapula. By doing so, trapezius and sternocleidomastoid activity is minimized, therefore removing or reducing contribution from cranial nerve XI.

Overall, the authors conclude that the RLS test is a novel, practical bedside maneuver that can help raise suspicion for C4 radiculopathy and complement the neurological examination, although confirmatory imaging or diagnostic blocks remain necessary.

Comments: The findings from this study highlight the clinical application of the RLS test as a new bedside diagnostic tool for patients with C4 radiculopathy.

Why is this interesting/relevant to the AANEM audience? Cervical radiculopathies are common in clinical practice, and isolated C4 radiculopathy is difficult to diagnose clinically. Presentation may masquerade as musculoskeletal shoulder pathology. Additional clinical diagnostic tools can help in selecting patients for further diagnostic testing.